Reumatología
Servicio
University of Washington School of Medicine
Seattle, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Washington School of Medicine (6)
2024
-
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Seminars in Arthritis and Rheumatism, Vol. 65
2022
-
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613
2020
-
Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
ACR Open Rheumatology, Vol. 2, Núm. 8, pp. 459-470
2018
2015
-
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis
Journal of Rheumatology, Vol. 42, Núm. 3, pp. 479-488
2014
-
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
Annals of the Rheumatic Diseases, Vol. 73, Núm. 6, pp. 1020-1026